AC
TARO

Armistice Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Armistice Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-245,372
Closed -$7.36M – 245
2022
Q3 		$7.36M Buy
245,372
+81,372
+50% +$2.81M 0.13% 83
2022
Q2 		$5.93K Buy
+164,000
New +$6.25M 0.1% 97

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Armistice Capital's TARO Position: Q4 2022 in Review

Armistice Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2022, closing a stake of 245,372 shares — an estimated $7.36M sold.

Armistice Capital first reported a position in TARO in Q2 2022 and held it in 2 quarters. The position peaked at $7.36M in Q3 2022. 62 funds tracked by Wall St. Rank hold TARO as of Q4 2022.

  • Armistice Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2022 after selling out during the quarter.
  • Armistice Capital sold 245,372 Taro Pharmaceutical Industries Ltd. shares in Q4 2022, an estimated $7.36M.
  • Armistice Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2022 and held it in 2 quarters.
  • Armistice Capital's Taro Pharmaceutical Industries Ltd. position peaked at $7.36M in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2022.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.